Stocks Hitting New 52-Week Highs for 11/21: ANDS, HSTM, IDIX, INHX, SPPI

Despite the stock market being deep in the red, there are stocks hitting new 52-week highs today. These stocks including Anadys Pharmaceuticals, Inc. (NASDAQ:ANDS), Healthstream Inc. (NASDAQ:HSTM) Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX), Inhibitex, Inc. (NASDAQ:INHX) and Spectrum Pharmaceuticals, Inc (NASDAQ:SPPI).

Anadys Pharmaceuticals Inc. (NASDAQ:ANDS) is unchanged right now at $3.69, but did hit a new 52-week high earlier today at $3.70. ANDS has traded 206 thousand shares so far today and on average trades 253 thousand shares. The company has a current market cap of 211.95 million.

Healthstream Inc. (NASDAQ:HSTM) is up 0.39% at $17.83. Earlier today, Healthstream hit a new 52-week high at $18.30. HSTM has traded 350 thousand shares today, well above its daily average of 143 thousand shares. The company has a current market cap of 396.24 million.

Idenix Pharmaceuticals Inc. (NASDAQ:IDIX) is down 1.48% at $7.30 after hitting a new 52-week high at $8.05 shortly after market open. Pharmaceutical companies have been seen extremely volatile trading today after the buyout of Pharmasset by Gilead for $11 billion. IDIX has traded 1.05 million shares so far today, well above its daily average of 651 thousand shares. The company has a current market cap of 698.07 million.

Inhibitex, Inc. (NASDAQ:INHX) is up 19.93% today at $10.69. INHX hit a new 52-week high at $11.98 shortly after the opening bell. INHX has traded 8.8 million shares today, about 8 times its daily average. The company has a current market cap of 836.95 million.

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) is up 6.24% at $12.93. SPPI hit a new 52-week high at $13.00 earlier today. The FDA approved the removal of the bioscan requirement for the company’s drug Zevalin. The stock has traded 1.6 million shares so far today, 600 thousand more than its daily average. The company has a current market cap of 737.09 million.

written by

An avid market watcher, Martin enjoys the tech arena the most with the Nasdaq being his main area of focus. A finance major, Martin is working to the goal of one day ringing the bell at the NYSE.
Related Posts

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

© Copyright - Active Investor
Real Time Analytics